An interventional study of Toolkit for Optimal Recovery after Concussion (TOR-C) and Health Enhancement after Concussion (HE-C) in Concussion (Diagnosis), Mild Traumatic Brain Injury and Post Concussion Symptoms, sponsored by Massachusetts General Hospital. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Prevention
The goal of this study is to test the efficacy of the Toolkit for Optimal Recovery after Concussion (TOR-C), a brief live-video mind-body program. aiming to prevent chronic concussion symptoms and optimize recovery.
141 studies on the registry are indexed under Post-Concussion Syndrome; 34 are open to participants now.
This study's planned enrollment of 260 is above the median of 52 across 114 interventional studies indexed under Post-Concussion Syndrome.
Browse Post-Concussion Syndrome studies →Massachusetts General Hospital is the lead sponsor of 2,586 studies on the registry; 447 are open to participants now.
Of its 222 completed or terminated interventional studies of FDA-regulated products, 168 (76%) have results posted.
Compared within Post-Concussion Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Brain Concussion. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A 4-week mind-body program delivered via live video (Zoom) 1:1 with a clinician delivering mind-body and cognitive-behavioral skills.
Behavioral: Toolkit for Optimal Recovery after Concussion (TOR-C)
A 4-week program delivered via live video (Zoom) 1:1 with a clinician delivering psychoeducation and information about healthy living after a concussion
Behavioral: Health Enhancement after Concussion (HE-C)
TOR-C is a brief behavioral mind-body program delivered remotely via live video over four weekly 45-minute sessions, with approximately 10 minutes of daily home practice. It targets anxiety and fear-avoidance factors to prevent chronic concussion symptoms, combining mind-body skills (e.g., mindfulness, deep breathing, acceptance), light cognitive-behavioral skills, skills for gradual return to activity, and concussion psychoeducation.
HE-C is an attention-matched active control program delivered remotely via live video over four weekly 45-minute sessions, with approximately 10 minutes of daily home practice. It provides general health education after concussion (e.g., sleep, nutrition, physical activity) without the specific skills included in TOR-C.
Post-Concussion Symptom Scale (PCSS)
Measures the severity of concussion symptoms (e.g., headache, fatigue, dizziness, difficulty concentrating). This is the study's primary outcome; efficacy is judged mainly on reducing these symptoms.
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Generalized Anxiety Disorder scale (GAD-7)
Measures the severity of anxiety symptoms. (Also used at screening, where a score ≥5 is required for eligibility.)
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Patient Health Questionnaire-9 (PHQ-9)
Measures the severity of depression symptoms.
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Fear Avoidance Behavior after Traumatic Brain Injury (FAB-TBI)
Measures fear-avoidance behavior, i.e., avoiding activities out of fear they will worsen symptoms. A core mechanism in the fear-avoidance model.
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Symptom Catastrophizing Scale
Measures the tendency to catastrophize concussion symptoms (magnifying, ruminating on, or feeling helpless about them).
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Measures mindfulness, i.e., present-moment awareness and acceptance of thoughts and feelings.
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Behavioral Response to Illness Questionnaire (BRIQ): Limiting behavior subscale
Measures the tendency to limit or avoid various activities in response to medical conditions
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Pittsburgh Sleep Quality Index (PSQI)
An exploratory outcome which measures sleep quality over the past month.
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
PROMIS Cognitive Function
An exploratory outcome which measures self-reported cognitive function (e.g., perceived problems with memory, attention, and thinking).
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
WHO Disability Assessment Schedule (WHODAS 2.0; 12-item version)
It is 12-item measure of health-related functioning and disability across daily activities (e.g., cognition, mobility, self-care, social participation) over the past 30 days, with higher scores indicating greater disability.
Time frame: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
Plan to share: Yes — We plan to share our study protocol, analysis plan, data dictionary, and de-identified data from all measures described under "outcome measures"
Supporting information: Study protocol, Statistical analysis plan
Time frame: Data from this study will be deposited into the Vivli database no later than one year of the completion of the funded project period
Access criteria: Interested parties can create an account in the Vivli Database and submit a request to access study data
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital →